The Latest Cardiac and Vascular News
Initial study shows Genetesis, Inc.’s CardioFlux Magnetocardiograph (MCG) has potential to rule patients out for Coronary Artery Disease. MASON, Ohio, Jan. 30, 2020 /PRNewswire/ — Undiagnosed chest pain sends 8-10 million Americans to Emergency Departments annually, making it the second most common complaint. Emergency physicians must rapidly identify patients whose chest pain is […]
Biofourmis’ artificial intelligence-powered RhythmAnalytics® to provide clinical decision support that IDs cardiac arrhythmias and other issues requiring intervention BOSTON, Jan. 30, 2020 /PRNewswire/ — Biofourmis, a fast-growing global leader in digital therapeutics that powers personally predictive care, and ImagineMIC™ announced a partnership agreement today to drive improved outcomes and lower healthcare costs for […]
– Early preclinical studies show peptide D6PV has the ability to activate the enzyme called Lipo-Protein Lipase (LPL), rapidly (within 1 -3 hours) reducing the number of triglycerides in the bloodstream – D6PV, an investigational drug, is being developed to address high triglyceride-induced acute pancreatitis (AP), a condition for which […]
BOSTON, Jan. 29, 2020 /PRNewswire/ — Cardiovascular disease (CVD) must be better managed for patient care to improve. The protocols for monitoring patients are rapidly evolving. Historically, patients who fall ill are required to travel in order to visit a general practitioner or hospital. This procedure may soon become a thing of the […]
Asymptomatic Patients Received Repetitive HBOT Protocols to Evaluate Sustained Cardiac Effect TEL AVIV, Israel, Jan. 30, 2020 /PRNewswire/ — The Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center, one of the largest hyperbaric treatment centers in the world, today announced the results of a study that – for the first time in […]
SANTA CRUZ, Calif.–(BUSINESS WIRE)–Emboline™, Inc., developer of embolic protection technology for brain and body during transcatheter aortic valve replacement (TAVR), today announced the closing of a $5 million bridge round of financing from a number of existing and new investors. This financing is ahead of an expected Series C financing […]
CHICAGO–(BUSINESS WIRE)–Chicago-based medical device firm Attune Medical announced the presentation of clinical results from the largest device study to date designed to evaluate the performance of its ensoETM patient temperature management device as an aid in the reduction of esophageal injury during cardiac ablation, a common treatment for atrial fibrillation. […]
Eko’s algorithms alert clinicians to the presence of heart murmurs and atrial fibrillation (AFib) during the physical exam, converting the classic stethoscope into a powerful early detection tool SAN FRANCISCO–(BUSINESS WIRE)–Eko, a digital health company applying artificial intelligence (AI) in the fight against heart disease, announced today that the U.S. […]
– The PULSAR trial achieved its primary endpoint: a statistically significant reduction in pulmonary vascular resistance – – The trial also achieved statistically significant improvements in the key secondary endpoint of six-minute walk distance (6MWD) and other secondary endpoints, including amino-terminal brain natriuretic propeptide (NT-proBNP), and World Health Organization (WHO) […]
New Larger Implant Enables Focal Dissection Repair Across a Wider Range of Vessel Sizes WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced Food and Drug Administration PMA approval for the expansion of its Tack Endovascular System® (6F) portfolio. The new approved device […]
